BioTech Medics, Inc. [formerly (PINKSHEETS: BTME), now (PINKSHEETS: BMCS)] announces the notice from NASDAQ according to The Exchange Act Rule 10b-17 to approve a reverse stock split and symbol change from BTME to BMCS effective at the open of the stock market today. On October 25, 2007, pursuant to Section 78.320 of the Nevada Revised Statutes, a majority of shareholders of BioTech Medics, Inc. consented to amend the Articles of Incorporation to a 1 for 20 reverse stock split for the outstanding shares of common stock. As a result of the stock split, each twenty (20) shares of common stock issued and outstanding before the effectiveness of the split shall be exchanged for one (1) share of common stock after the split. No small shareholders will be cashed out. Fractional shares will be rounded up to the next whole share. The Amendment was filed with the Nevada Secretary of State on Nov. 5, 2007. The outstanding shares (o/s) will be approximately 8.09 million at the open of today’s market. The authorized shares remain at 500 million, there are no preferred shares issues.
